Rayno Biopharmaceutical Portfolio Nov. 1, 2013 YTD Performance…Update 1
Updated 2/11/15 see chart below Rayno 2013 Picks Outperform Biotechnology Indices and Funds Biopharmaceutical stocks hit all time highs in 2013 with major ETFs up as follows YTD: FBT ($65) up 41%, IBB ($206) up 50%, and XBI ((%120) up 36%. The Five Star Fidelity Select Biotechnology Fund...
Rayno Life Science Scoreboard- October 2013- Amidst Sell-Off
Equities: The Only Game in Town With Rates Under 3%? October, normally a month to be cautious on the market, proved that trends can be misleading even in the midst of turbulent times in Washington. DOW Up 2.5%, S&P Up 3.5%, NASDAQ Up 2.5%. Healthcare stocks followed suit with the broadly...
Risk Rising in Mid and Small Cap Biopharmaceutical Stocks Update 2p EDT
Profit Taking Continues With Speculative Biotech Stocks Many of you who trade biopharmaceutical stocks know that $1B may be considered a small cap stock. As we mentioned in yesterday's post there is weakness in many high flying biotech stocks compared to the larger caps. Today the weakness is...
Biotechnology Bull Market Gets Second Wind To All Time Highs: ALR, GILD, ILMN,
Dow, S&P and Biotech Sector Hit All Time Highs NASDAQ Still 1000+Pts Under 2000 High Levels After a 10% sell-off in early October many large cap biopharmaceutical and diagnostic stocks are at new highs with the major indices at or near their October highs. The bellwether ETF IBB ($211.30)...
Rayno Life Science Update #2: ALKS, ALXN, IMGN Up on Q3 Reports
Biopharmaceutical stocks were somewhat mixed today yet we have some nice moves in our portfolio: Alexion (ALXN $125.26) up 7.34% on Q3 Results which showed a 36% increase in sales to $400M and Net Income (GAAP) of $93.8M up from $92.2M in the same quarter of 2012. The Company has $1.3B in cash....